Figure 3From: Lack of relationship between TIMP-1 tumour cell immunoreactivity, treatment efficacy and prognosis in patients with advanced epithelial ovarian cancer Kaplan Meier Overall Survival (OS) curves and TIMP-1. Median OS for patients with TIMP-1 negative tumours (N = 139): 23.7 months [19.0-29.4] 95% CI. Median OS for patients with TIMP-1 positive tumours (N = 21): 15.9 months [12.3-27.4] 95% CI.Back to article page